US stock · Healthcare sector · Diagnostics & Research
Company Logo

Syneos Health, Inc.

SYNHNASDAQ

48.02

USD
-0.11
(-0.23%)
Market Closed
18.40P/E
9Forward P/E
0.92P/E to S&P500
4.929BMarket CAP
- -Div Yield

Syneos Health, Inc.

NASDAQ:SYNH

RECENT
PRICE

48.02

P/E
RATIO

18.40

(PEG:0.85)

P/E RATIO
RELATIVE
TO S&P

0.92

DIV
YLD

0.00%

High:
Low:

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

0
0

Legends

Stock price

1.75 Beta (1.0 Market)

0

0

0

0

0

0

0

0

0

-

% total return 09/22:

Stock

S&P

1y.

0

0

3y.

0

0

5y.

0

0

0

Percent shares traded:

0

0

0

- -

- -

- -

- -

- -

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

TTM

Fiscal year

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

12.64

(1.15)

(0.45)

0.09

16.74

(1.14)

0.64

0.01

16.55

(0.69)

0.33

0.01

22.12

(0.44)

1.99

0.01

24.17

2.02

3.17

- -

29.81

2.08

1.44

- -

35.67

(1.85)

2.06

- -

42.45

0.23

2.41

- -

45.13

1.27

2.46

- -

42.39

1.85

3.60

- -

50.04

2.25

3.78

- -

52.41

2.70

3.12

- -

Revenue per share

Earnings per share

Free Cash Flow per sh

Dividends per share

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

0.09

- -

0.18

6.10

0.29

4.59

0.48

7.36

0.36

3.76

0.58

5.58

0.59

40.35

0.53

27.62

0.62

29.24

0.48

31.12

0.55

32.76

0.80

32.31

CAPEX per share

Book Value per share

- -

- -

- -

- -

- -

52

52

60

53

58

54

75

103

104

104

104

103

Comm.Shares outs.(m)

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

- -

(52.9)

(2.9)

0.0%

18.7

0.9

- -

21.3

1.0

- -

(27.4)

(1.2)

- -

188.4

7.5

- -

38.8

1.6

- -

31.6

0.8

- -

38.2

1.3

- -

18.4

0.9

- -

Avg. annual P/E ratio

P/E relative to S&P500

Avg. annual div. yield

Capital Structure (30/6/22 | Q2)

Total liabilities
$4,888 m.

Total assets
$8,217 m.

Long-term debt
$3,043 m.

Cash and equiv.
$106 m.

Goodwill $4,898 m.

Retained earnings $25 m.

Common stock 103 m. shares

Market Capitalisation
$4,929 m. (as of 26/9/22)

656

(6.1)%

869

(4.3)%

995

3.2%

1,179

5.4%

1,399

10.9%

1,611

9.6%

2,672

(1.1)%

4,390

3.6%

4,676

5.1%

4,416

6.6%

5,213

7.5%

5,419

8.0%

Revenue (m)

Operating margin

64

(60)

79

(59)

58

(42)

55

(23)

56

117

59

113

180

(138)

274

24

242

131

222

193

236

235

1,217

278

Depreciation (m)

Net profit (m)

36.8%

(9.1)%

37.7%

(6.8)%

(35.4)%

(4.2)%

16.8%

(2.0)%

10.6%

8.4%

16.0%

7.0%

(23.8)%

(5.2)%

57.6%

0.6%

(29.1)%

2.8%

5.3%

4.4%

25.5%

4.5%

23.9%

5.1%

Income tax rate

Net profit margin

- -

- -

- -

44

586

317

58

587

276

47

415

392

(53)

472

217

56

486

301

263

2,946

3,023

(11)

2,737

2,856

46

2,550

3,030

161

2,902

3,242

112

3,016

3,413

174

3,043

3,329

Working capital (m)

Long-term debt (m)

Equity (m)

- -

- -

- -

(2.1)%

(2.6)%

(18.7)%

4.5%

2.4%

(15.0)%

2.4%

2.0%

(6.0)%

17.8%

12.1%

53.8%

14.9%

11.3%

37.4%

(1.0)%

(0.7)%

(4.6)%

1.4%

2.6%

0.9%

5.0%

3.1%

4.3%

1.6%

1.4%

5.9%

4.5%

4.8%

6.9%

(6.2)%

(6.5)%

8.4%

ROIC

Return on capital

Return on equity

Working Capital

2019

2020

2021

Cash assets

164

272

106

Receivables

1,304

1,345

1,525

Inventory

- -

- -

- -

Other

95

121

135

Current assets

1,562

1,738

1,766

Acc. Payable

137

114

108

Debt due

114

60

64

Other

1,266

1,404

1,483

Current liab.

1,516

1,577

1,654

107.6%

- -

100.8%

- -

101.2%

- -

101.6%

- -

100.0%

156.0%

100.0%

82.7%

100.0%

- -

100.0%

30.1%

100.0%

22.3%

100.0%

18.7%

100.0%

29.9%

100.0%

46.4%

Plowback ratio

Div.&Repurch. to FCF

Syneos Health, Inc. (US) started trading on November 5, 2014 (cik: 0001610950), operates in the Healthcare sector (Diagnostics & Research industry), has 26,751 full-time employees, and is led by Mr. Alistair Macdonald. Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, devices, and digital therapeutics in the Phase I to IV of clinical development. This segment also provides individual services, including product development and regulatory consulting, project management, protocol development, investigational site recruitment, clinical monitoring, technology-enabled patient recruitment and engagement, clinical home health, clinical trial diversity, biometric, and regulatory affair services. The Commercial Solutions segment provides commercialization services, including deployment solutions, communications solutions, such as public relations, advertising, and medical communication services; and consulting services to the pharmaceutical, biotechnology, and healthcare industries. The company was formerly known as INC Research Holdings, Inc. and changed its name to Syneos Health, Inc. in January 2018. Syneos Health, Inc. was incorporated in 2010 and is headquartered in Morrisville, North Carolina.

Annual rates

(avg rate of change)

Past
5 y.

Past
10 y.

Revenues

20.82%

24.00%

Cash flow

28.95%

69.96%

Earnings

97.91%

-56.33%

Dividends

- -

- -

Book value

3.21%

104.30%

Insider trading

Type

Shares

Date

Brooks Michael Lee

Sale

500

07/28/22

Brooks Michael Lee

Sale

1,002

07/28/22

Brooks Michael Lee

Sale

500

07/21/22

Brooks Michael Lee

Sale

1,002

07/21/22

Olefson Jonathan

Sale

2,215

07/20/22

Fiscal Year Ends

Quarterly Revenue (m)

Full fiscal year

I

II

III

IV

2020

1,163

1,013

1,099

1,140

4,416

2021

1,209

1,283

1,348

1,373

5,213

2022

1,336

1,361

- -

- -

- -

Fiscal Year Ends

Earnings per share

Full fiscal year

I

II

III

IV

2020

0.32

0.04

0.61

0.88

1.85

2021

0.37

0.40

0.75

0.73

2.25

2022

0.45

0.76

- -

- -

- -

Fiscal Year Ends

Quarterly dividends paid

Full fiscal year

I

II

III

IV

2020

- -

- -

- -

- -

- -

2021

- -

- -

- -

- -

- -

2022

- -

- -

- -

- -

- -